Category: CovidienSyndicate content

Covidien launches new Trellis clot-busting device

July 8, 2014 by Brad Perriello

Covidien says its launched the latest version of the Trellis peripheral infusion system designed to dissolve blood clots above the knee.

Covidien launches new Trellis clot-busting device

Covidien (NYSE:COV) said today it's launched the Trellis clot-busting platform in the U.S., Europe and Canada.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien's Nellcor and CAS Medical settle dispute for $275k

July 7, 2014 by Arezu Sarvestani

Nellcor agrees to drop its litigation in return for a $275,000 payment and a promise from Nellcor to drop its claims for legal fees.

Covidien's Nellcor and CAS Medical settle dispute for $275k

Covidien taps integration chief to navigate Medtronic merger

July 3, 2014 by Arezu Sarvestani

Covidien appoints Europe division CFO Bill Burke to navigate its end of the $43 billion acquisition by Medtronic.

Covidien taps integration chief to navigate Medtronic merger

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Podcast: Medical device execs react to Medtronic-Covidien deal, M&A activity at DeviceTalks Minnesota

July 3, 2014 by Brian Johnson

MassDevice.com speaks to 3M's Deb Rectenwald, St. Jude Medical's Philip Ebeling and Nadim Yared, CEO of CVRx, about the environment for M&A in medtech following the $43 billion Medtronic/Covidien deal.

MassDevice.com DeviceTalks

Medtech trends: The most talked about device makers in June 2014

July 3, 2014 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

Podcast: Covidien's Enxing Seng talks Medtronic merger, future of medicine at DeviceTalks

July 1, 2014 by Brian Johnson

Covidien's Stacy Enxing Seng speaks to MassDevice.com about the Medtronic merger during our DeviceTalks Minnesota event.

MassDevice.com sat down with Stacy Enxing Seng, executive in residence at Covidien (NYSE:COV), just a week after the company announced it had agreed to be acquired by Medtronic (NYSE:MDT) for $43 billion.

MassDevice.com +3 | The top 3 medtech stories for June 27, 2014

June 27, 2014 by Brad Perriello

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp